Compared with opioids, other high impact drug classes like topicals, compound kits, combo packs, and specialty medications, represent proportionately low volume. However, they can be associated with exponentially significant costs. Recognizing the trends related to such cost drivers can help promote clinically-appropriate savings. Watch the video blog to learn more.
More stories
A New Era of Performance Management
As McKinsey and Company stated in their 2017 study on performance management, “What gets measured, gets done.”1 Performance management is a critical aspect of success in any field of business, and this is especially true in the world of auto physical damage claims. Success comes in many forms in the claims industry, from managing costs to producing proper and safe repairs.
StateWatch: Fall 2018
Keep current with new legislation and its potential effect on your organization. This regulatory update is for informational purposes only, and provides some key highlights on state initiatives that may impact the services Genex provides.
Press Release - Coventry and Paradigm Outcomes Join Together
Risk & Insurance: When Faced With Workers' Comp Chaos, This Risk Manager Restructured the Way Claims Were Handled
For a staffing company with claims out of control, Kathleen Peck tore the program down and built it back up to achieve success, which earned
StateWatch: Fall 2018
The FDA has approved a non-opioid, percutaneous electrical nerve field stimulator device as an aid to reduce opioid withdrawal symptoms during detoxification.